MTOR and hepatocellular carcinoma: More recently, it has been documented that GSTA1-1 negatively regulates the mTOR signaling pathway and the over-expression of the isoenzyme in hepatocellular carcinoma cells showed enhanced AMPK activity and subsequent inhibition of the mTOR pathway.